Zuckerberg's Biohub Invests $500M in AI Cellular Models

Mark Zuckerberg’s Chan Zuckerberg Biohub has announced a $500 million investment to develop artificial intelligence models that simulate human biology at the cellular level. The initiative, part of a five-year plan, aims to create predictive models of human cells to accelerate the cure and prevention of all diseases. Approximately $400 million will fund internal AI development, while the remainder supports third-party researchers. Biohub scientists state that achieving accurate biological representation requires significantly more data and new observation technologies ranging from molecular to tissue levels. This ambitious health research project coincides with reports that Meta paid a record-low federal income tax rate of roughly 3.5% in 2025, despite generating $79 billion in profits. Critics highlight the discrepancy between Meta’s tax contributions and the funding allocated to this private scientific endeavor, suggesting that the unpaid taxes could have substantially supported public health programs. The article frames the initiative as a prestige project for billionaires, drawing comparisons to similar efforts by Bill Gates and Warren Buffett, while questioning the allocation of resources in the context of corporate tax avoidance.